Aquestive Therapeutics, Inc.
AQST· Nasdaq
AQSTAquestive Therapeutics, Inc.
Quarterly figures for Aquestive Therapeutics, Inc., with source filings when available.
38 quarters. Mar 31, 2017 to Jun 30, 2026. USD.
Aquestive Therapeutics, Inc. has filed its 10-Q within 35 to 43 days of period end across its last 8 quarters. The 10-K runs 63 to 90 days.
Aquestive Therapeutics, Inc. · CIK 1398733 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 11, 2026 · after-hours | Aug 11, 2026 | 42 d | 10-Q | $13.82M | +38.1% | -$0.18 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 13, 2026 · after-hours |
| May 13, 2026 |
| 43 d |
| 10-Q |
| $14.45M |
| +65.7% |
| -$0.07 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 4, 2026 · after-hours | Mar 4, 2026 | 63 d | 10-K | $13.02M | +9.7% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 5, 2025 · after-hours | Nov 5, 2025 | 36 d | 10-Q | $12.81M | −5.4% | -$0.14 | |
| Q2 2025 | Jun 30, 2025 | Aug 11, 2025 · after-hours | Aug 11, 2025 | 42 d | 10-Q | $10.00M | −50.2% | -$0.14 | |
| Q1 2025 | Mar 31, 2025 | May 12, 2025 · after-hours | May 12, 2025 | 42 d | 10-Q | $8.72M | −27.7% | -$0.24 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 5, 2025 · after-hours | Mar 5, 2025 | 64 d | 10-K | $11.87M | −10.1% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 4, 2024 · after-hours | Nov 4, 2024 | 35 d | 10-Q | $13.54M | +4.2% | -$0.13 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · after-hours | Aug 6, 2024 | 37 d | 10-Q | $20.10M | +51.8% | -$0.03 | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · after-hours | May 7, 2024 | 37 d | 10-Q | $12.05M | +8.3% | -$0.17 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 5, 2024 · after-hours | Mar 5, 2024 | 65 d | 10-K | $13.21M | +23.6% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · after-hours | Nov 6, 2023 | 37 d | 10-Q | $13.00M | +13.4% | -$0.03 | |
| Q2 2023 | Jun 30, 2023 | Aug 7, 2023 · after-hours | Aug 7, 2023 | 38 d | 10-Q | $13.24M | −0.2% | -$0.10 | |
| Q1 2023 | Mar 31, 2023 | May 2, 2023 · after-hours | May 2, 2023 | 32 d | 10-Q | $11.13M | −9.3% | $0.11 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 7, 2023 · after-hours | Mar 31, 2023 | 90 d | 10-K | $10.68M | −3.6% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 1, 2022 · after-hours | Nov 1, 2022 | 32 d | 10-Q | $11.46M | −13.7% | -$0.23 | |
| Q2 2022 | Jun 30, 2022 | Aug 2, 2022 · after-hours | Aug 2, 2022 | 33 d | 10-Q | $13.27M | −13.6% | -$0.36 | |
| Q1 2022 | Mar 31, 2022 | May 3, 2022 · after-hours | May 4, 2022 | 34 d | 10-Q | $12.27M | +10.3% | -$0.32 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 8, 2022 · after-hours | Mar 8, 2022 | 67 d | 10-K | $11.08M | +55.0% | — | |
| Q3 2021 | Sep 30, 2021 | Nov 2, 2021 · after-hours | Nov 2, 2021 | 33 d | 10-Q | $13.29M | +60.9% | -$0.37 | |
| Q2 2021 | Jun 30, 2021 | Aug 3, 2021 · after-hours | Aug 3, 2021 | 34 d | 10-Q | $15.35M | −29.2% | -$0.33 | |
| Q1 2021 | Mar 31, 2021 | May 4, 2021 · after-hours | May 4, 2021 | 34 d | 10-Q | $11.12M | +26.9% | -$0.41 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | Mar 9, 2021 · after-hours | Mar 9, 2021 | 68 d | 10-K | $7.15M | −56.5% | -$0.60 | |
| Q3 2020 | Sep 30, 2020 | Nov 4, 2020 · after-hours | Nov 4, 2020 | 35 d | 10-Q | $8.26M | −33.5% | -$0.49 | |
| Q2 2020 | Jun 30, 2020 | Aug 4, 2020 · after-hours | Aug 4, 2020 | 35 d | 10-Q | $21.68M | +94.8% | -$0.07 | |
| Q1 2020 | Mar 31, 2020 | May 5, 2020 · after-hours | May 5, 2020 | 35 d | 10-Q | $8.77M | −30.7% | -$0.49 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | Mar 11, 2020 · after-hours | Mar 11, 2020 | 71 d | 10-K | $16.42M | −2.4% | -$0.48 | |
| Q3 2019 | Sep 30, 2019 | Nov 5, 2019 · after-hours | Nov 5, 2019 | 36 d | 10-Q | $12.42M | −6.4% | -$0.74 | |
| Q2 2019 | Jun 30, 2019 | Aug 6, 2019 · after-hours | Aug 6, 2019 | 37 d | 10-Q | $11.13M | −20.1% | -$0.82 | |
| Q1 2019 | Mar 31, 2019 | May 8, 2019 · market hours | May 8, 2019 | 38 d | 10-Q | $12.64M | −46.0% | -$0.59 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | Mar 14, 2019 · market hours | Mar 14, 2019 | 73 d | 10-K | $16.82M | +38.0% | -$0.56 | |
| Q3 2018 | Sep 30, 2018 | Nov 6, 2018 · after-hours | Nov 6, 2018 | 37 d | 10-Q | $13.27M | −51.1% | -$0.64 | |
| Q2 2018 | Jun 30, 2018 | Sep 4, 2018 · market hours | Sep 4, 2018 | 66 d | 10-Q | $13.93M | +25.0% | -$1.90 | |
| Q1 2018 | Mar 31, 2018 | — | — | — | — | $23.41M | +42.4% | $0.27 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | — | — | — | $12.19M | — | — | |
| Q3 2017 | Sep 30, 2017 | — | — | — | — | $27.15M | — | — | |
| Q2 2017 | Jun 30, 2017 | — | — | — | — | $11.14M | — | — | |
| Q1 2017 | Mar 31, 2017 | — | — | — | — | $16.44M | — | — | |
